Khan I, Awan SA, Rizwan M, Ali S, Zhang X, Huang L (2021) Arsenic behavior in soil-plant system and its detoxification mechanisms in plants: a review
Molecular Characteristics Compound Name: 5-Amino-1MQ CAS Number: 42464-96-0 Compound Class: Quinoline derivative small molecule Form: Encapsulated research compound Purity: 99% analytical purity Unit Size: 50mg capsules (60 count) Stability Profile and Storage Recommendations Store in a cool, dry environment Protect capsules from moisture and light Avoid excessive heat exposure Maintain sealed packaging when not in use Follow standard laboratory storage practices Solubility and Preparation Considerations Capsule contents may be dissolved in compatible laboratory solvents Suitable for biochemical assay buffer systems Compatible with aqueous laboratory solutions May be used in metabolic pathway assay preparations Compatible with standard in-vitro research protocols Technical Specifications product Name 5-Amino-1MQ 50mg Capsules brand BioPeptides cas 42464-96-0 purity 99% analytical purity unit Size 50mg capsules (60 count) form Encapsulated research compound synthesis Controlled chemical synthesis analytical HPLC and purity verification molecular Structure Quinoline-based small molecule stability Stable when stored in dry conditions Analytical Validation and Quality Assurance Purity verification using analytical testing Compound identity confirmation Batch-to-batch consistency evaluation Chemical stability verification Manufacturing quality control procedures Regulatory and Compliance Statement 5-Amino-1MQ supplied by BioPeptides is intended strictly for laboratory and scientific research use only
[] Benzodiazepines work by modulating gamma-aminobutyric acid (GABA-A) receptors
RDA : 40 mcg/day Deficiency Selenium deficiency is rare in healthy humans
4G, Suppl
Designing prodrugs that are inactive in the systemic circulation but are selectively activated by enzymes overexpressed in diseased tissues (e.g., cathepsins and matrix metalloproteinases) allows for the localized release of active copper-modulating agents, thereby minimizing off-target effects [257]
